AC Immune SA
Compositions of phosphorylated tau peptides and uses thereof

Last updated:

Abstract:

Liposomes containing tau peptides, preferably phosphorylated tau peptides, and conjugates containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier are described. Pharmaceutical compositions and uses of the liposomes and/or conjugates for treating or preventing a neurodegenerative disease or disorder, such as Alzheimer's Disease, are also described.

Status:
Grant
Type:

Utility

Filling date:

24 Oct 2018

Issue date:

21 Sep 2021